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Macrophages play a central role in the pathogenesis of many chronic inflammatory 
lesions (1). By virtue of their functions, strategic location, and wide tissue distribution, 
these  cells can  determine  susceptibility and  resistance to infection.  It appears that 
macrophages  can  delay  and  prevent  the  spread  of  infection  to  susceptible  cells. 
However,  where  infectious  agents  with  cytopathic  properties  can  replicate  freely 
within  macrophages,  widespread  destruction  of tissues  may  follow.  Furthermore, 
infected circulating macrophages can disseminate infection by migration through the 
vascular compartment, with distribution of an infectious agent to susceptible organs. 
Inflammatory lesions may also result from a  series of events starting with the direct 
interaction of infectious agents with the macrophage. This results in the production 
of monokines, which  stimulate T  cells to release lymphokines, which  stimulate the 
macrophage bearing the infectious agent, e.g., listeria monocytogenes (2,  3). Macro- 
phages, in addition to their phagocyte functions, can secrete substantial quantities of 
hydrolytic  enzymes  as  well  as  other  biologically  active  products  in  response  to 
inflammatory stimuli. Such products may contribute to the pathogenetic process (4). 
A second host defense system that may be activated in response to infection is the 
coagulation system. The consumption of proteins of the coagulation pathways coupled 
with  the  local or disseminated  intravascular  formation or deposition  of fibrin  is of 
diagnostic significance in a number of lesions, including acute proliferative glomeru- 
lonephritis  (5),  Henoch-Schonlein  purpura  (6),  hyperacute renal  allograft rejection 
(7), acute tubular necrosis (8), lupus erythematosus (9), and the Shwartzmann reaction 
(10). The perivascular deposition of fibrin is one of the earliest features of experimental 
allergic  encephalomyelitis  (11).  Activation  of the  coagulation  system  is  frequently 
associated with active rheumatoid arthritis and other connective tissue diseases (12). 
Cells  of the  lymphoreticular system possess low basal  procoagulant  activity of a 
poorly defined character;  however, significant  procoagulant activity (PCA) 1 can be 
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induced by a variety of stimuli, including lipopolysaccharides (LPS), antigen-antibody 
complexes,  and  lectins  (13-20).  We  have  recently  established  (14,  16)  that  the 
monocyte and macrophage represent  the cellular sources of LPS and antigen:anti- 
body induced  PCA  and  that  lymphocyte/macrophage collaboration  is  a  necessary 
requirement for the full induction of PCA response. Current evidence suggests this is 
an  immune  response  that  functions  via  unidirectional  lymphocyte  induction  of 
procoagulant monokines. 
The murine hepatitis viruses (MHV) are a group of serologically related pathogenic 
coronaviruses (21, 22). Infection of mice by MHV may produce a broad spectrum of 
diseases,  including  encephalitis,  hepatitis,  interstitial  pneumonitis,  nephritis,  and 
enteritis, depending on the serotype of MHV, the age and strain of the mouse, and 
the  route  of infection  (23).  Murine  hepatitis  virus  type 3  (MHV-3)  is  a  primarily 
hepatotropic  serotype  and  causes  hepatitis  when  administered  intraperitoneally, 
intracerebrally, intravenously, or orally in susceptible strains of mice (24, 25). Balb/c 
and DBA/2 mice develop acute fulminant hepatitis, C3H mice develop a mild chronic 
disease, and mice of the A strain develop no evidence of hepatitis (26). The mechanism 
of resistance to MHV infection in animals is both complex and poorly understood. It 
has been demonstrated that resistance to fatal MHV infection may be associated with 
a resistance gene that inhibits MHV replication in macrophages and is also influenced 
by a susceptibility factor that is related to lymphocytes (26-30). 
In this study, we demonstrate that the induction by lymphocytes of monocyte PCA 
in response to MHV-3 infection reflects the susceptibility of the host to infection by 
MHV-3.  We further indicate  that  there exists a  genetic restriction  in  the MHV-3- 
induced  pathway  of lymphoreticular  PCA.  This  is  characterized  by  the  lack  of 
generation  of PCA  in  the resistant  animal,  modest  induction  in  mice that  develop 
mild  and  chronic  disease,  and  a  profound  PCA  response  by  the  fully  susceptible 
animal who develops fatal hepatitis. The induction of lymphoreticular PCA antedates 
viral replication and appearance of histologic lesions in susceptible organs. Further- 
more, we demonstrate that  the  monocyte is the cellular source of this activity but 
cellular collaboration between lymphocytes and monocytes is required for the gener- 
ation of the PCA response. 
Materials and Methods 
Cells.  The origin and growth of 17 CL1, DBT, and L2 cells has been described previously 
(31-33).  Cells were routinely propagated in Dulbecco's modified Eagle's medium (DMEM) 
(Flow Laboratories Inc., Rockville,  Md.) supplemented with 10% newborn calf serum (Biocell 
Laboratories,  Carson  City,  Calif.)  and  25  #g/ml  chlortetracycline  hydrochloride  grade  II 
(Sigma Chemical Co.,  St.  Louis,  Mo.)  and buffered with  15 mM Hepes, 3-[N-morpholino]- 
propanesulfonic acid, N-tris [hydroxymethyl] 3 methyl-2 aminoethane sulfonic acid, and 4 mM 
glutamine (Sigma Chemical Co.). 
Peripheral blood mononuclear cells (PBM) were isolated  from mice as previously described 
(14). The cells were separated over Ficoll-Hypaque (density,  1.074 g/ml) at 22°C for 12 rain at 
1,400 g and were recovered at the interface.  The cells were adjusted  to  1 x  106 PBM/ml. 
Lymphocytes and monocytes were separated by adherence to plastic,  as previously described 
(14). The recovery of cells was >86% and viability was >98%, as evidenced by trypan blue 
exclusion.  Lymphocytes were  defined  by failure of adherence,  morphology, and  failure of 
uptake of neutral red and were <2% esterase positive. Monocytes were defined by morphology 
and uptake of neutral red and were >96% esterase positive, as previously described (14). 
Mice.  C3H/St,  A/J,  and  BALB/c  mice  (Research  Institute of Scripps  Clinic  breeding 1152  MONOCYTE  PROCOAGULANT ACTIVITY BY  MURINE  HEPATITIS VIRUS 
colony) were used at 4-6 wk of age. After infection with MHV-3, they were maintained in strict 
isolation. 
Virus.  MHV-3 was obtained from the American Type Culture Collection, Rockville, Md. 
(ATTCC VR-262), and the lyophilized infected liver homogenate was reconstituted with 1 ml 
sterile phosphate-buffered  saline  (PBS),  pH  7.4.  The  virus  was  plaque  purified  twice  on 
monolayers of DBT cells. The virus was subsequently passaged once in DBT cells to prepare a 
seed stock. A  working stock of virus was grown in  17 CL1  cells infected at a  multiplicity of 
infection (MOI) of 10  -4 plaque-forming units (PFU)/eelI. This stock virus had a titer of 1.2 × 
10  v PFU/ml and was used for all subsequent experiments. Virus was assayed on monolayers of 
L2 cells in a standard plaque assay, as previously described (31-34). Lethal dose--50% (LDso) 
was  determined  in  BALB/c, C3H/St,  and  A/J  mice  and  was calculated according to  the 
method of Reed and Mueneh (35), using an endpoint of 10 d. 
PCA  Assay.  PCA was determined in  a  one-stage recalcified clotting assay, as previously 
described (16).  Samples of frozen-thawed and sonicated cells in RPMI  1640 were assayed for 
the Capacity to shorten the spontaneous clotting of human plasma. The assay consisted of 50 
#1  of test sample, 50 #l of 25  mM CaC12, and  50 #1  of citrated normal-fasting platelet-poor 
human  plasma. Units were assigned from a  log-log plot and  standardized with dilutions of 
rabbit brain thromboplastin (Dade Div., American Hospital Supply Corp., Miami, Fla.), which 
at 36/~g/ml was assigned a  value of 100,000  mU. There was no activity present in DMEM, 
RPMI  1640, PBS, complete media, or the virus preparations. 
Endotoxin Contamination.  DMEM, RPMI 1640, PBS, and virus preparations were assayed for 
endotoxin  contamination  by  standard  limulus  assay  (E.  toxate; Sigma  Chemical  Co.)  and 
contained <0.1  ng/ml of endotoxin in the lower limits of this test (36, 37). 
Results 
Resistance  of Mice to Lethal Infection  with MHV-3.  28 BALB/c mice were infected in 
groups of seven with  1,  10,  100, or 1,000 PFU of MHV-3 by intraperitoneal injection 
and were observed for  10 d  (Table I). Using the method of Reed and Muench  (35), 
an LDs0 for BALB/c of <  1-5 PFU was established. In similar experiments, the LDs0 
for C3H/St  was ~  106 PFU, and A/J mice were resistant to >107 PFU. 
MHV-3 Replication  In  Vitro.  The one-step growth curve of MHV-3  in  17 CL 1 cells 
was  determined after innoculation of cultures at  an  MOI  of 0.1  PFU/cell, and  the 
virus titers in replicate cultures were determined at various subsequent time intervals 
(Fig. 1). MHV-3 had an eclipse phase of 4- to 5 h, reaching a  maximum virus titer at 
10 h  postinfection. 
One-step  growth  curves  were  then  determined  in  monocytes  harvested  from  the 
peripheral blood of A/J, BALB/c and C3H/St  mice. For these experiments mice were 
killed, and  PBM  were  isolated  asceptically over  Ficoll-Hypaque.  Monocytes  were 
separated from lymphocytes by adherence to plastic for 48 h  and were >92% esterase 
positive (38). Monocytes at 3 ×  105 were seeded in 24-well cluster plates (Costar Data 
TABLE  I 
LDso of MHV-3 for BALB/c Mice 
Group*  Dose MHV-3*  Mortality 
PFU  % 
1  1  71 
2  l0  67 
3  100  84 
4  1,000  100 
* Each group contained seven mice. 
:~ MHV-3 given in 100 pl of PBS by intraperitoneal injection. G.  A.  LEVY, J.  L.  LEIBOWITZ,  AND  T.  S.  EDGINGTON 
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Fzc.  1.  One-step growth curve of MHV-3 in 2 X  10  7 | 7 CLI cells. Cells were infected in suspension 
with  MHV-3  at  an  MOI  of 0.1  (29).  After virus adsorption  for  30  rain  at  37°C,  the cells were 
collected by low-speed centrifugation and resuspended in media containing 2% FCS, and replicate 
cultures were seeded at 1 ×  10  e cells per 12 X 35-ram culture dish. At appropriate intervals, cultures 
were frozen, and the cells were harvested by freeze-thawing, scraped with a  rubber policeman, and 
disrupted by sonication. The homogenates were then clarified by centrifugation, and virus titer was 
determined by  plaque  assay at  serial  10-fold  dilutions.  Each data  point  represents the  mean of 
duplicate cultures, and each line represents individual experiments. 
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Packaging, Cambridge, Mass.) in  1 ml DMEM fortified with 2% fetal calf serum and 
were infected at an MOI of 0.1  with MHV-3. Virus was adsorbed to the cells for 60 
min at  37°C.  Unadsorbed  virus was removed by washing with  DMEM,  the media 
were replaced, and the cells were further incubated at 37°C. Cultures were frozen at 
appropriate  intervals,  treated  as  described  above, and  assayed for virus  by plaque 
assay at  serial  10-fold dilutions  (Fig.  2).  In contrast  to the  growth of MHV-3  in  a 
totally permissive cell line (17 CLI), in BALB/c monocytes, a prolonged period of 16 
h  was observed postinfection,  during which  time no  virus replication  was evident. 
However, subsequent  to the  16-h lag period,  replication  was progressive, with peak 
yields 24  h  after infection.  In contrast,  no virus replication  was detected  in A/J or 
C3H/St monocytes within 48 h  postinfection. These observations parallel the obser- 
vations of acute fulminant hepatitis in BALB/c mice and resistance of A/J mice to 
overt hepatitis or death. 
Basal Cellular PCA.  The total cellular content of PCA immediately after isolation 
of cells and before any form of in vitro culture was determined for A/J, BALB/c, and 
C3H/St  mice and was remarkably consistent at  56-81  mU/106 PBM.  This activity 
rises spontaneously to a  maximum stable concentration of 515 mU/106 PBM within 
6  h  of culture  in  serum-free medium  in  the  absence of added  stimulus  (Table II). 
When the control cultured cells were fractionated by adherence into lymphocytes and 1154  MONOCYTE  PROCOAGULANT ACTIVITY BY MURINE HEPATITIS VIRUS 
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FIG.  2.  One-step growth curve for MHV-3 in BALB/c, (0), C3H/St (11), and A/J (&) monocytes. 
Monocytes were isolated from PBM by adherence to plastic.  3 ×  10  s monocytes were added to each 
well of 24-well cluster plates and  infected with MHV-3 at  an  MOI of 10  -l. The infection was 
allowed to continue for various time intervals and then the virus was recovered by freeze-thawing 
and scraping of the plates with a rubber policeman. The virus was clarified by centrifugation and 
then assayed in a plaque assay. Each data point represents  the mean of duplicate cultures• 
TABLE II 
Basal Levels of PCA m PBM 
Strain 
Total content PCA/106 PBM* 
Time zero~  6 h in culture§ 
mU 
A/J  56 ±  14  485 ±  110 
BALB/c  74 ±  12  515 ±  75 
C3H/St  81 ±  20  500 ±  100 
* Total content PCA is determined by measuring an aliquot of freeze-thawed 
and disrupted cells. 
:~ Time zero is defined as time immediately after isolation  of cells. 
§ Cells are cultured with no stimulus in RPMI  1640 for 6 h  in 5% CO2 at 
37°C. 
monocytes,  74%  of the  basal  PCA  was  accounted  for  in  the  latter  cells  (esterase 
positive)  in all strains tested, which agrees with results reported  previously (16). 
MHV-3 Induction  of PCA.  PBM  were isolated from each of the mice strains,  and  1 
X  108  PBM  were  incubated  with  106  PFU  of MHV-3  for  18  h  at  37°C  in  1 ml  of 
RPMI  1640  supplemented  with  2%  heat-inactivated  FCS  at  37°C.  The  cells  were 
washed  three  times  with  RPMI  1640,  disrupted,  and  assayed  for  total  PCA.  As  a 
positive control,  1  ×  106  PBM  from  each  strain  was  stimulated  with Escherichia  coli 
011 l:B4  LPS  at  10 #g/ml,  as  previously  described  (16).  Cells  from  all  three  strains 
responded  to LPS with a  six- to eightfold increase in PCA  (Table III), in accord with 
previous observations  (16).  The  PCA  response of BALB/c  PBM  to  106  PFU  MHV-3 G.  A.  LEVY, J.  L.  LEIBOWITZ,  AND T.  S.  EDGINGTON  1 155 
was  greater  than  previously observed  for any stimulus,  reaching  levels  of >70,000 
mU/106  PBM  (Table  III).  In contrast  to  the  profound  PCA  response  of BALB/c 
PBM, no response to MHV-3 was observed in PBM  from A/J  mice, even though a 
normal  PGA response was observed  to LPS stimulation.  A  moderate  PCA response 
was observed for PBM from C3H/St mice stimulated with MHV-3, but the response 
was only  70%  of the  response  observed  for LPS stimulation  (Table  III). Thus,  the 
PCA response of PBM to MHV-3 stimulation exhibited  profound strain differences. 
The production of the PGA by PBM correlates with the susceptibility of the strain to 
hepatic disease. Furthermore, the PCA response of BALB/c mice was of a  magnitude 
15-20 times  greater than that observed for the response to LPS or antigen-antibody 
complexes (14-16). No increase in PCA above basal levels was observed when  1 X  106 
PBM from BALB/c, A/J, or C3H/St mice were cultured with an aliquot from mock- 
infected DBT, L2, or 17 GL 1 cells (data not shown). 
Dose-response titrations were examined for MHV-3-induced PCA in which 1 x  106 
PBM  from  BALB/c  mice were  incubated  for  6  h  with  MHV-3.  When  1  PFU  of 
MHV-3 was used, a fourfold increase in PCA as compared with unstimulated control 
cultures was observed (Fig. 3). A  dose-dependent increase of PCA achieved a  168-fold 
maximum increase of PCA with  106 PFU of MHV-3 (Fig. 3). 
Comparable  experiments  were  conducted  with  PBM  from  C3H/St  and  A/J 
mice. When  1 X  106 PBM from C3H/St  mice were incubated for 6 h with increasing 
amounts of MHV-3, no PGA response was observed until concentrations of 100 PFU 
of MHV-3 were added; and the maximum PCA response was observed at  105 PFU of 
MHV-3, with a  7.2-fold maximum increase in PCA observed over control cultures. In 
contrast, no PCA response was observed for PBM from A/J mice over a dose titration 
of 1-106 PFU of MHV-3. 
To determine the kinetics of MHV-3-induced amplification of PCA,  1 X  106 PBM 
from  BALB/c,  G3H/St,  and  A/J  mice  were  each  incubated  with  106  PFU  of 
MHV-3 for various time intervals and assayed for total cellular PCA. A  10-fold PCA 
response  was  observed  for BALB/c PBM  that  were cultured  for  1 h  with  MHV-3 
(Fig.  4).  There  was  a  progressive  increase  of PGA  with  time  of exposure,  which 
reached a  maximum of 84,500 mU at  12 h. This level of PGA was maintained  for 48 
h, which was the maximum interval of observation. In contrast, the PCA response of 
C3H/St  mice did not rise until  2 h  after exposure to MHV-3 and was maximum at 
8  h  (Fig.  4)  at  2,800 mU, which was a  6.8-fold  increase  over control.  Finally,  there 
was no increase in PCA from A/J mice above a  background level of 385 mU at any 
time interval of cultivation  (Fig. 4). 
MHV-3 Stimulation  of Cell  Populations.  When  isolated  lymphocytes or monocytes 
TABLE III 
MHV-3 Induction of PCA m PBM in Inbred Strains of Mice 
PCA (mU/106  MHV-3§  Strains  Control*  PBM) LPS:]: 
A/J  540 :t= 120  4,250 + 200  710 3= 150 
BALB/c  605 3= 140  3,850 3= 100  74,560 3= 1,250 
C3H/St  550 :l: 200  4,100 :t: 150  2,850 3= 105 
* Control levels taken from cells cultured for 6 h after isolation. 
10/xg LPS added to PBM in experiment. 
61  6  § 10  PFU in a volume of 100/~1 added to 10  PBM. 1156  MONOCYTE  PROCOAGULANT ACTIVITY  BY  MURINE  HEPATITIS  VIRUS 
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FIG. 3.  Dose-response  curve for MHV-3-induced PCA in PBM from BALB/c, C3H/St,  and A/J 
mice. 1 ×  l0  s PBM from Balb/c (O), C3H/St (g), and A/J (A) mice were infected with serial 10- 
fold dilutions of virus for 18 h, and then PBM was assayed for total content of PCA in a one-stage 
clotting assay. 
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FxG. 4.  Time-course for the induction of murine PCA by MHV-3. 1 X  10  6 PBM from BALB/c 
(O), C3H/St (11), and A/J (A) mice were cultured with 1 ×  l0  s PFU of MHV-3 and then freeze- 
thawed and were sonieated and assayed in a one-stage clotting assay for total content of PCA. 
from  either  C3H/St  or  BALB/c  mice  were  directly  stimulated with  MHV-3,  no 
increase of cellular PCA was observed  (Table IV).  However, when PBM were  first 
stimulated by MHV-3 for 18 h  and then subsequently fractionated into lymphocytes 
and monocytes by adherence to plastic for 48 h, the increase in PCA observed for the 
whole PBM was localized to the monocyte population. This is similar to the increase 
demonstrated for  LPS stimulation (14).  The PCA response of PBM  from  BALB/c 
mice was  168-fold, increasing from 505 to 81,400 mU. 98% of the increase in PCA 
could be accounted for in the monocyte fraction, which demonstrated an increase in 
total  cellular PCA  from  3,200  (control)  to  722,000  mU/10  ~ monocytes  (Table V). G.  A.  LEVY, J.  L.  LEIBOWITZ, AND T.  S.  EDGINGTON 
TABLE IV 
Failure of lnduction of PCA by Direct MHV-3 Stimulation of Cells Isolated 
from PBM  from BALB/c and C3H/St Mice 
MHV-3 stimulated cells* 
BALB/c  C3H/St 
Stimu-  Stimu- 
mU  lated/  mU  lated/ 
basal  basal 
PBM  84,300  156  3,500  9.2 
Lymphoeyt  es.t  64  1.3  56  0.9 
Monocytes§  3,450  1.1  2,950  0.8 
* 106 PFU of MHV-3 added in all cultures. 
:~ Lymphocytes separated by adherence to plastic and directly stimulated by 
MHV-3. Lymphocytes  were <2% esterase positive. 
§ Monocytes separated on  the  basis of adherence to  plastic and directly 
stimulated by MHV-3. Monocytes  were >96% esterase positive. 
TABLE  V 
Cellular Source of MHV-3-induced PCA in Subpopulations  from PBM in BALB/c 
and C3H/St Mice 
1157 
Cell population* 
PCA/10  6 cells 
BALB/c  C3H/St 
Stimu-  Stimu- 
mU  lated:]:/  mU  lated~:/ 
basal  basal 
PBM  81,400  168  3,150  7.1 
Lymphocytes§  48  0.9  51  1.3 
Monoeytes[[  722,000  172  28,500  8.1 
* Cells were held in culture for 18 h and then assayed for total content of PCA. 
:~ 10  s PFU of MHV-3 added in all cultures. 
§ Lymphocytes  separated on the basis  of  adherence to plastic after MHV-3 stimulation 
of PBM. Lymphocytes represent 86% of the total cell population and are <2% 
esterase positive. 
I[ Monocytes separated on the basis of adherence to plastic after MHV-3 stimulation 
of PBM. Monocytes represent 12-14% of PBM and are >96% esterase positive. 
Similar analyses were  conducted with  C3H/St  cells.  Although the  total  PCA  was 
considerably less  than that  observed for  PBM  from  BALB/c mice  (Table IV),  the 
cellular distribution was  similar.  Even with  cellular subfractionation there  was  no 
increase in PCA in monocytes from A/J mice (data not shown). It is apparent that 
the monocyte is the cellular source of increased PCA; however, direct stimulation of 
monocytes did not result in increased PCA. A further requirement appeared essential 
for the monocyte PCA response. 
Lymphocyte Requirement  for Generation of Monocyte PCA.  To further explore the cellular 
requirements  for  the  induction of  the  monocyte  PCA  response,  monocytes  were 
prepared by 48-h incubation and adherence to plastic. Lymphocytes were vigorously 
washed  away  and >99%  of the  remaining cells  in  the  16-mm  Diam  plastic  wells 
demonstrated  active  uptake  of neutral red.  Upon detachment and  preparation of 
cytologic smears, virtually all cells were positive for nonspecific esterase. Such mono- 
cytes, though admittedly now with a  more macrophagelike cytology and behavior, 1158  MONOCYTE  PROCOAGULANT  ACTIVITY  BY  MURINE  HEPATITIS  VIRUS 
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FIG.  5.  Lymphocyte requirement for the induction of PCA by MHV-3.  1 x  105 monocytes from 
BALB/c (Q), C3H/St (I), and A/J (A) mice were stimulated with 1 X  105 PFU of MHV-3, either 
alone or with increasing numbers of lymphocytes for 16-18 h. Monocytes were then isolated from 
the lymphocytes and assayed for total content of PCA. 
were prepared from C3H/St, A/J,  and BALB/c mice. They were stimulated either 
directly by MHV-3 alone attached in the  16-mm plastic wells or in the presence of 
variable numbers of lymphocytes, i.e., with lymphocyte:monocyte ratios from 0:1 to 
8:1. Monocytes were then isolated from lymphocytes by vigorous washing and assayed 
for total cellular PCA.  Monocytes (1  ×  10  5) exposed to  10  6 PFU of MHV-3  in the 
absence of lymphoeytes exhibited no PCA response, nor was the response at lympho- 
cyte:monocyte ratios  of less  than  2:1  particularly  notable  (Fig.  5).  However,  at 
lymphocyte'monocyte ratios  of 2.5:1  or  greater,  a  significant  PCA  response  was 
observed and  it  reached maximum  levels as  the  ratio approached 4:1.  No  further 
increase in PCA was noted as the ratio was increased to 8:1. These data indicate that 
monocytes are the cellular source of the MHV-3-induced PCA, but the presence of 
lymphocytes is necessary for induction of the PCA response in monocytes. 
Discussion 
This study further characterizes the generation of monocyte procoagulant activity 
in response to stimuli, a response mediated by the coagulation pathways. In previous 
reports, we have demonstrated that monocytes from a wide variety of mouse strains, 
including the A/J, BALB/c, and C3H/St used in this study, produce an equivalent 
PCA response to such agents as LPS (14,  16) and antigen-antibody complexes (15). 
Others  (13,  17-20)  have  observed  this  response  in  a  variety of species,  including 
human and rabbit, using lectins, LPS, and antigen-antibody complexes. 
In the present study, a genetically restricted pathogenic agent, MHV-3, stimulates 
the PCA response of cells only from strains of mice susceptible to the pathologic effects 
of the virus. This, to our knowledge, is the first example of a normal genetic restriction 
of the PCA response and is characterized by maximum output of PCA by BALB/c 
mice  that  are  fully susceptible  to  MHV-3,  with  a  fatal  outcome within  6-7  d,  a 
moderate PCA response of C3H/St mice who develop enzymatic and histologic lesions 
of hepatitis  (G.  A.  Levy, J.  L.  Leibowitz,  and  T.  S.  Edgington,  manuscript  in 
preparation), and no PCA response of mice fully resistant to MHV-3, as exemplified 
by the A/J strain.  We have shown that these strains are all functionally capable of G. A. LEVY, J.  L. LEIBOWITZ, AND T. S.  EDGINGTON  1159 
producing a PCA response to LPS  2 and also to antigen:antibody complexes (unpub- 
lished data)  and that the magnitude of the PCA response is equivalent,  a Therefore, 
the lack of response by the A/J  strain  to MHV-3  is specific for the stimulus.  The 
response  of cells  from  C3H/St  mice  is  comparable  to  that  observed  for  other 
unrestricted stimuli, such as LPS  2 or antigen:antibody complexes (15) and before this 
study  would  have been  considered a  maximum  response.  Of great  interest  is  the 
unprecedented  response  of cells  from  BALB/c  mice.  It  represents  -30  times  the 
response observed for any other previously examined stimulus,  including those re- 
ported by other investigators (17-20). Whether or not the increased magnitude of the 
response represents increased synthesis of procoagulant molecules, a  new and as yet 
uncharacterized initiator of the coagulation pathways or conformation realignment 
of either tissue  factor or  the  monocyte prothrombinase  (39)  and  amplification  of 
activity by a cofactor such as factor Va (40) remains to be investigated. 
MHV-3-induction of the  PCA  response  is  also  more rapid  than  was  previously 
observed,  with  a  significant  increase  of PCA  within  1-1.5  h  in  vitro  and  with 
maximum activity at 12-18 h. This contrasts to the 2-3-h lag period before monocyte 
PCA  increases  in  response to  LPS-triggered lymphocytes. Virus  growth  in  a  fully 
susceptible cloned cell line (17 CL1) was not detectable until 6 h after infection, and 
in  monocytes  from  BALB/c  mice  infectious  virus  was  not  produced  until  18  h 
postinfection. Thus, the induction of the PCA response in PBM antedates production 
of infectious virus and cannot be ascribed to it per se. Furthermore, little or no viral 
replication occurred in monocytes from C3H/St mice, and yet a robust generation of 
monocyte PCA followed. Thus, these initial observations suggest that the induction 
of the PCA response by PBM does not depend on virus replication. 
The induction of this activity temporally precedes induction by other stimuli, such 
as LPS or antigen-antibody complexes, as reported previously. At 2 h, although only 
6% of total virally induced PCA is seen in the susceptible BALB/c strain, the quantity 
of PCA exceeds a maximum response by other agents, such as LPS. We have recently 
described (16) the kinetic characteristics and metabolic requirements for the induction 
of lymphoreticular PCA.  We demonstrated,  using  LPS as  a  model stimulus,  that 
lymphocyte triggering by this stimulus was a brief event, requiring only 5-10 min for 
detectable  effect  and  30  min  for  maximum  triggering.  Lymphocyte contact  and 
induction  of monocytes required  15  min  for complete effect, but  monocytes then 
required an additional 4 h  for production of maximum PCA. In the viral induction 
of PCA, it appears there are differences in the kinetics of induction of PCA, with an 
initial response in just  1.5 h, although maximum PCA induction requires  12-16 h. 
This is not simply a matter of recruiting more monocytes or macrophages because we 
have demonstrated (14) in cytologic assays that virtually all monocytes/macrophages 
are recruited in the previously described responses. Thus, it is possible that different 
cellular mechanisms or products are operative for the induction of PCA by different 
stimuli. 
We have extended these observations by demonstrating that lymphocyte collabo- 
ration  is  necessary  for  the  induction  of monocyte  PCA.  When  highly  purified 
monocytes from C3H/St or BALB/c strains of mice are directly stimulated by the 
2  Levy,  G. A., and T. S. Edgington. The major histocompatibility  requirement  for cellular  collaboration  in 
the  murine lymphoid procoagulant response stimulated by bacterial lipopolysaccharide. Manuscript 
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virus, no induction of PCA follows. These results parallel the PCA response to other 
stimuli  (14-16).  In studies  involving human  PBM  (41,  42), we have observed that 
both helper and suppressor lymphocytes exist that  appear central to the induction 
and regulation of the PCA response to LPS. Indeed, the induction of monocyte PCA 
by  helper T  cells  can  be  markedly  attenuated  by Ty cells.  This  finding  may  be 
significant  in  explaining the response to MHV-3.  It  is  possible that  the  failure of 
response by PBM  from A/J  mice could reflect an excess of suppressor cells rather 
than  a  lack of lymphocyte recognition and  generation of triggered T  helper cells. 
Furthermore, the different responses observed in C3H/St and  BALB/c mice could 
reflect similar disproportions in the suppressor and helper cell participants. Another 
possible explanation of the differences in  PCA  induction  by MHV-3 could reflect 
differences in  the  capacity of monocytes to receive signals  from  MHV-3-triggered 
lymphocytes or otherwise accept lymphocyte collaboration for this specific stimulus. 
The lack of a  monocyte subpopulation  (which is inducible) by MHV-3 within A/J 
mice might explain the failure of induction of PCA in this strain. Application of the 
cytologic PCA assay previously described (16), in which we can visualize individual 
cells and the presence or absence of PCA, promises to provide additional information. 
A  number of investigators  (26,  27)  have demonstrated  that  the susceptibility of 
adult  mice of different strains to MHV, using mortality as the index, parallels the 
cytopathic effects that  the virus has in mouse peritoneal macrophages in vitro. The 
cellular basis for the resistance of A strain macrophages is not known; however, it has 
been observed (26)  that resistance can be overcome by increasing the infecting dose, 
suggesting that resistant strains do not entirely lack receptors for MHV-3. It has also 
been demonstrated  (43-45) that young or immunologically depressed A strain mice 
develop disease similar to that occurring in susceptible strains, in contrast to the fully 
resistant adult A mouse. Further observations suggest that the state of susceptibility 
is under the influence of T  cells (46-48), humoral factors (28), and splenic adherent 
cells  (27).  It has also been demonstrated  (46,  47)  that  nude mice and  mice treated 
with cyclophosphamide (49) develop full susceptibility to MHV-3 infection. Thus, it 
appears that  a  complex series of interactions between lymphocytes, monocytes, and 
humoral  factors may be required to explain  the  balance between  susceptibility or 
resistance to this virus. 
The present study reports that  PBM  from susceptible strains of mice respond to 
MHV-3  with  a  rapid  and  robust  PCA  response.  In  contrast,  there  is  a  failure of 
induction of PCA in the fully resistant A/J strain. Although most mechanistic details 
remain to be resolved, this system provides a biochemical marker for susceptibility to 
MHV-3-induced disease and perhaps may play a role in the pathogenesis of disease 
induced by this virus. 
Summary 
The in vitro induction of procoagulant activity (PCA) in murine peripheral blood 
mononuclear cells (PBM) by murine hepatitis virus type 3 (MHV-3) correlates with 
the disease susceptibility in three strains of mice. PBM from BALB/c mice, a  strain 
in which MHV-3 infection results in fatal acute fulminant hepatitis, responds to the 
virus with a  robust PCA response, whereas PBM from C3H/St mice, a strain which 
develops mild acute hepatitis  followed by chronic hepatitis,  only exhibit a  modest 
PCA response. In contrast, PBM from A/J mice, a strain fully resistant to MHV-3, G.  A.  LEVY, J.  L.  LEIBOWITZ,  AND T.  S.  EDGINGTON  1161 
generate  no increase  in  PCA above control  levels.  The  induction  phase of MHV-3 
PCA is rapid, with an increase within  1-1.5 h, with maximum activity at  18 h, and 
it precedes MHV-3 replication  in either  17 CL1  cells, a  fully permissive cell line,  or 
in monocytes from these strains of mice. The PCA response of BALB/c PBM exceeds 
the response to any other known stimulus. No induction occurs upon direct stimulation 
of monocytes by MHV-3, but in the presence of lymphocyte collaboration, the PCA 
response  is  observed  first  at  a  lymphocyte:monocyte  ratio  of  2:1  and  reaches  a 
maximum as the lymphocyte:monocyte ratio approaches 4:1. 
This response appears to provide a  functional marker for susceptibility to MHV-3 
infection  in  inbred  strains  of mice  and  could  be  important  in  the  pathogenesis  of 
MHV-3-induced disease. 
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